Abstract
To analyse the contributions of metabolic toxicity of high glucose level and accompanying
hyperosmolality to the development of diabetic neuropathy, mouse dorsal root ganglion
(DRG) cultures were used. DRGs from postnatal day 7 mice were embedded in collagen
gel and incubated in RPMI 1640 culture medium with increasing concentrations of glucose
or equimolar amounts of mannitol which would create similar osmolalities. Outgrowth
of axons from the peripheral nerve attached to DRG and migration of cells into the
gel were quantified. The extent of cell death, apoptosis and mitosis among the migrating
cells and apoptosis among DRG neurons following exposure to high glucose or mannitol
were also evaluated. The growth of axons was almost equally affected by increasing
concentrations of glucose or mannitol up to 395 mOsm/kg H2 O. Number of migrating cells was close to control values with mannitol between 340–395 mOsm/kg
H2 O while high concentrations of glucose always decreased it. Exposure to high glucose
or mannitol led to increased proportions of dead and apoptotic migrating cells and
apoptotic DRG neurons. Mitotic activity was also negatively affected by high glucose
or mannitol. While glucose proved significantly more detrimental to migrating cells
than mannitol in the latter tests, the extent of apoptosis was similar among DRG neurons
in both conditions. In conclusion, the contribution of hyperosmolality to the development
of neuropathy in high glucose condition appears to be quite significant. The peripheral
nerve cells and neurons, however, are differentially affected by hyperosmolality and
metabolic toxicity of high glucose.
Key words
diabetic neuropathy - dorsal root ganglion - high glucose - hyperosmolality - mannitol
References
1
Almhanna K, Wilkins PL, Bavis JR, Harwalkar S, Berti-Mattera LN.
Hyperglycemia triggers abnormal signaling and proliferative responses in Schwann cells.
Neurochem Res.
2002;
27
1341-1347
2
Bagnasco SM, Uchida S, Balaban RS, Kador PF, Burg MB.
Induction of aldose reductase and sorbitol in renal inner medullary cells by elevated
extracellular NaCl.
Proc Natl Acad Sci USA.
1987;
84
1718-1720
3
Bhardwaj A, Harukuni I, Murphy SJ. et al .
Hypertonic saline worsens infarct volume after transient focal ischemia in rats.
Stroke.
2000;
31
1694-1701
4
Bisby MA.
Axonal transport of labeled protein and regeneration rate in nerves of streptozocin-diabetic
rats.
Exp Neurol.
1980;
69
74-84
5
Braaten JT.
Hyperosmolar nonketotic diabetic coma: diagnosis and management.
Geriatrics.
1987;
42
83-88,92
6
Burg MB.
Role of aldose reductase and sorbitol in maintaining the medullary intracellular milieu.
Kidney Int.
1988;
33
635-641
7
Busik JV, Hootman SR, Greenidge CA, Henry DN.
Glucose-specific regulation of aldose reductase in capan-1 human pancreatic duct cells
in vitro.
J Clin Invest.
1997;
100
1685-1692
8
Chakrabarti S, Sima AA, Nakajima T, Yagihashi S, Greene DA.
Aldose reductase in the BB rat: isolation, immunological identification and localization
in the retina and peripheral nerve.
Diabetologia.
1987;
30
244-251
9
Chung SS, Ho EC, Lam KS, Chung SK.
Contribution of polyol pathway to diabetes-induced oxidative stress.
J Am Soc Nephrol.
2003;
14
S233-S236
10
Copp J, Wiley S, Ward MW, Geer P Van Der.
Hypertonic shock inhibits growth factor receptor signaling, induces caspase 3 activation,
and causes reversible fragmentation of the mitochondrial network.
Am J Physiol Cell Physiol.
2004;
11
Ekstrom AR, Kanje M, Skottner A.
Nerve regeneration and serum levels of insulin-like growth factor-I in rats with streptozotocin-induced
insulin deficiency.
Brain Res.
1989;
496
141-147
12
Faradji V, Sotelo J.
Low serum levels of nerve growth factor in diabetic neuropathy.
Acta Neurol Scand.
1990;
81
402-406
13
Flyvbjerg A, Orskov H.
Diabetic angiopathy: new experimental and clinical aspects.
Horm Metab Res.
2005;
37
(Suppl 1)
1-3
14
Fu SY, Gordon T.
The cellular and molecular basis of peripheral nerve regeneration.
Mol Neurobiol.
1997;
14
67-116
15
Fulop M, Rosenblatt A, Kreitzer SM, Gerstenhaber B.
Hyperosmolar nature of diabetic coma.
Diabetes.
1975;
24
594-599
16
Hellweg R, Hartung HD.
Endogenous levels of nerve growth factor (NGF) are altered in experimental diabetes
mellitus: a possible role for NGF in the pathogenesis of diabetic neuropathy.
J Neurosci Res.
1990;
26
258-267
17
Humpert PM, Papadopoulos G, Schaefer K. et al .
sRAGE and esRAGE are not associated with peripheral or autonomic neuropathy in type
2 diabetes.
Horm Metab Res.
2007;
39
899-902
18
Jakobsen J, Brimijoin S, Skau K, Sidenius P, Wells D.
Retrograde axonal transport of transmitter enzymes, fucose-labeled protein, and nerve
growth factor in streptozotocin-diabetic rats.
Diabetes.
1981;
30
797-803
19
Kasalova Z, Prazny M, Skrha J.
Relationship between peripheral diabetic neuropathy and microvascular reactivity in
patients with type 1 and type 2 diabetes mellitus – neuropathy and microcirculation
in diabetes.
Exp Clin Endocrinol Diabetes.
2006;
114
52-57
20
Kennedy JM, Zochodne DW.
The regenerative deficit of peripheral nerves in experimental diabetes: its extent,
timing and possible mechanisms.
Brain.
2000;
123
((Pt 10))
2118-2129
21
Kim B, Feldman EL.
Insulin-like growth factor I prevents mannitol-induced degradation of focal adhesion
kinase and Akt.
J Biol Chem.
2002;
277
27393-27400
22
Ko BC, Ruepp B, Bohren KM, Gabbay KH, Chung SS.
Identification and characterization of multiple osmotic response sequences in the
human aldose reductase gene.
J Biol Chem.
1997;
272
16431-16437
23
Maekawa K, Tanimoto T, Okada S, Suzuki T, Yabe-Nishimura C.
Expression of aldose reductase and sorbitol dehydrogenase genes in Schwann cells isolated
from rat: effects of high glucose and osmotic stress.
Brain Res Mol Brain Res.
2001;
87
251-256
24
Matsuka Y, Spigelman I.
Hyperosmolar solutions selectively block action potentials in rat myelinated sensory
fibers: implications for diabetic neuropathy.
J Neurophysiol.
2004;
91
48-56
25
Matthews CC, Feldman EL.
Insulin-like growth factor I rescues SH-SY5Y human neuroblastoma cells from hyperosmotic
induced programmed cell death.
J Cell Physiol.
1996;
166
323-331
26
Mizisin AP, Li L, Calcutt NA.
Sorbitol accumulation and transmembrane efflux in osmotically stressed JS1 schwannoma
cells.
Neurosci Lett.
1997;
229
53-56
27
Mizisin AP, Li L, Perello M, Freshwater JD, Kalichman MW, Roux L, Calcutt NA.
Polyol pathway and osmoregulation in JS1 Schwann cells grown in hyperglycemic and
hyperosmotic conditions.
Am J Physiol.
1996;
270
F90-97
28
Mohiuddin L, Tomlinson DR.
Impaired molecular regenerative responses in sensory neurones of diabetic rats: gene
expression changes in dorsal root ganglia after sciatic nerve crush.
Diabetes.
1997;
46
2057-2062
29
Nukada H, Dyck PJ, Low PA, Lais AC, Sparks MF.
Axonal caliber and neurofilaments are proportionately decreased in galactose neuropathy.
J Neuropathol Exp Neurol.
1986;
45
140-150
30
Öztürk G, Sž ekerog˘ lu MR, Erdog˘an E, Öztürk M.
The effect of non-enzymatic glycation of extracellular matrix proteins on axonal regeneration
in vitro.
Acta Neuropathol.
2006;
112
627-632
31
Öztürk G, Erdog˘an E.
Multidimensional long-term time-lapse microscopy of in vitro peripheral nerve regeneration.
Microsc Res Tech.
2004;
64
228-242
32
Raghavendra S, Ashalatha R, Thomas SV, Kesavadas C.
Focal neuronal loss, reversible subcortical focal T2 hypointensity in seizures with
a nonketotic hyperglycemic hyperosmolar state.
Neuroradiology.
2007;
49
299-305
33
Reinehr R, Haussinger D.
Hyperosmotic activation of the CD95 system.
Methods in enzymology.
2007;
428
145-160
34
Ruepp B, Bohren KM, Gabbay KH.
Characterization of the osmotic response element of the human aldose reductase gene
promoter.
Proc Natl Acad Sci U S A.
1996;
93
8624-8629
35
Russell JW, Sullivan KA, Windebank AJ, Herrmann DN, Feldman EL.
Neurons undergo apoptosis in animal and cell culture models of diabetes.
Neurobiol Dis.
1999;
6
347-363
36
Scott JN, Clark AW, Zochodne DW.
Neurofilament and tubulin gene expression in progressive experimental diabetes: failure
of synthesis and export by sensory neurons.
Brain.
1999;
122
((Pt 11))
2109-2118
37
Sima AA, Sugimoto K.
Experimental diabetic neuropathy: an update.
Diabetologia.
1999;
42
773-788
38
Sugimura K, Windebank AJ, Natarajan V. et al .
Interstitial hyperosmolarity may cause axis cylinder shrinkage in streptozotocin diabetic
nerve.
J Neuropathol Exp Neurol.
1980;
39
710-721
39
Sugimoto K, Murakawa Y, Sima AA.
Diabetic neuropathy – a continuing enigma.
Diabetes Metab Res Rev.
2000;
16
408-433
40
Tilton RG, Chang K, Nyengaard JR, Enden M Van den, Ido Y, Williamson JR.
Inhibition of sorbitol dehydrogenase. Effects on vascular and neural dysfunction in
streptozocin-induced diabetic rats.
Diabetes.
1995;
44
234-242
41
Tonge D, Edstrom A, Ekstrom P.
Use of explant cultures of peripheral nerves of adult vertebrates to study axonal
regeneration in vitro.
Prog Neurobiol.
1998;
54
459-480
42
Unger JW, Klitzsch T, Pera S, Reiter R.
Nerve growth factor (NGF) and diabetic neuropathy in the rat: morphological investigations
of the sural nerve, dorsal root ganglion, and spinal cord.
Exp Neurol.
1998;
153
23-34
43
Williamson JR, Chang K, Frangos M, Hasan KS, Ido Y, Kawamura T, Nyengaard JR, Enden M
van den, Kilo C, Tilton RG.
Hyperglycemic pseudohypoxia and diabetic complications.
Diabetes.
1993;
42
801-813
44
Zhuang HX, Wuarin L, Fei ZJ, Ishii DN.
Insulin-like growth factor (IGF) gene expression is reduced in neural tissues and
liver from rats with non-insulin-dependent diabetes mellitus, and IGF treatment ameliorates
diabetic neuropathy.
J Pharmacol Exp Ther.
1997;
283
366-374
45
Zochodne DW, Verge VM, Cheng C, Sun H, Johnston J.
Does diabetes target ganglion neurones? Progressive sensory neurone involvement in
long-term experimental diabetes.
Brain.
2001;
124
2319-2334
Correspondence
Dr. G. Öztürk
Yyu Tip Fakultesi
Arastirma Hastanesi
Fizyoloji Abd
Van
65200 Turkey
Phone: +90/432/214 88 68
Fax: +90/432/214 88 68
Email: drgurkan@yyu.edu.tr